[1] CONNYE N. KURATKO Norman S Jr. Biomarkers of DHA status[J]. Prostaglandins, leukotrienes, and essential fatty acids, 2009, 81 2: Pages 111-118. DOI:
10.1016/j.plefa.2009.05.007[2] R.J.SCOTT LACOMBE Richard P B Raphaël Chouinard Watkins. Brain docosahexaenoic acid uptake and metabolism[J]. Molecular Aspects of Medicine, 2018, 64: Pages 109-134. DOI:
10.1016/j.mam.2017.12.004[3] CALDER P. Docosahexaenoic Acid[J]. Annals of Nutrition and Metabolism, 2016, 306 1: 8-21. DOI:
10.1159/000448262[4] MARIA C. BASIL Bruce D L. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation[J]. Nature Reviews Immunology, 2015, 16 1: 51-67. DOI:
10.1038/nri.2015.4[5] ILSE A C ARNOLDUSSEN Amanda J K. Impact of DHA on metabolic diseases from womb to tomb.[J]. Marine Drugs, 2014, 12 12: 6190-6212. DOI:
10.3390/md12126190